Quarterly SG&A run rate
Company: Core Scientific
The claim, verbatim
Management pointed investors to a roughly $30 million quarterly SG&A run rate for modeling 2027 consolidated EBITDA, while declining to give specific EBITDA guidance.
Source (primary)
[Core Scientific Q3 2026 Earnings Call] Colocation Revenue Jumps 60% to $215M, Adjusted EBITDA Triples to $134M as CoreWeave Capacity Hits 485 MW - BigGo Finance (-, news_article)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “the ~$30 million quarterly SG&A run rate”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms [Core Scientific Q3 2026 Earnings Call] Colocation Revenue Jumps 60% to $215M, Adjusted EBITDA Triples to $134M as CoreWeave Capacity Hits 485 MW - BigGo Finance
Quote: “the ~$30 million quarterly SG&A run rate”